Biota Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (20)

Latest Posts

About This Stock More About This Stock
ADMP Announces Positive Results For Its Dry Powder Inhaler Product; BOTA Commences Dosing In Vapendavir Phase 2b Trial
Article By: BioMedReports
Wednesday, March 4, 2015 5:15 AM EDT
ADMP announced the results of its pharmacokinetic (PK) study for its dry powder inhaler product, APC-5000. BOTA announced it has commenced dosing of patients in its Phase 2b SPIRITUS trial of vapendavir.
In this article: ADMP, BOTA

Latest Tweets for $BOTA

No tweets yet!